BridgeMD
New treatment option for Anterior Cruciate Ligament (ACL) Reconstruction
Official title Comparison of Bone-patellar Tendon-bone and Patellar Tendon-bone Grafts in ACL Reconstruction
ClinicalTrials.gov ID: NCT07475351
What this study is testing
- What it's testing
- The purpose of this randomized study is to compare donor site morbidity and clinical and functional outcomes of both surgery techniques (bone-patellar tendon-bone (BPTB) graft versus bone-patellar tendon without patellar bone plug (PT) graft) for anterior cruciate ligament reconstruction (ACLR) in athletes. The main questions it aims to answer are: Does PT graft reduce donor site morbidity compared to the standard BPTB graft?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 40
You may be able to join if
- Time for injury to surgery of less than six months.
- Active athletes (federated or recreational)
- Patellar tendon length \> 42mm measured by MRI.
- Age between 12 and 40 years old
- Genders eligible for Study: both
You likely can't join if
- Previous surgery or history of ligamentous knee injuries.
- Concomitant knee ligament injury
- Major meniscal injury (more than 50% of the lateral or medial meniscus)
- Chondral injury greater than Outerbridge Grade I-II
The study team makes the final eligibility decision.
Where it's taking place
- Granada, Granada, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Granada, Granada, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.